IL17A and infection: In addition, in vivo studies have revealed that IL-17A exacerbates the severity of lung infection as evidenced by the increase in serum IL-17A levels upon infection with Mycobacterium pulmonis and reduction in disease severity by neutralization of IL-17A in Balb/c mice [18].